Table. 1.
Patients’ Characteristics
| Factor | Group | Training cohort (N = 735) | Validation cohort (N = 324) | Joined cohort (N = 1059) |
|---|---|---|---|---|
| Age | 54 [14, 82] | 57 [15, 87] | 55 [14, 87] | |
| Gender (%) | M | 387 (52.6) | 165 (50.9) | 552 (52.1) |
| F (%) | 0 | 82 (11.2) | 111 (34.3) | 193 (18.2) |
| 1 | 252 (34.3) | 105 (32.4) | 357 (33.7) | |
| 2 | 150 (20.4) | 61 (18.8) | 211 (19.9) | |
| 3 | 204 (27.8) | 40 (12.3) | 244 (23.0) | |
| 4 | 47 (6.4) | 7 (2.2) | 54 (5.1) | |
| A (%) | 0 | 63 (8.6) | 96 (29.6) | 159 (15.0) |
| 1 | 347 (47.2) | 128 (39.5) | 475 (44.9) | |
| 2 | 257 (35.0) | 89 (27.5) | 346 (32.7) | |
| 3 | 68 (9.3) | 11 (3.4) | 79 (7.5) | |
| ALB (g/dL) | 4.4 [2.5, 5.4] | 4.5 [1.7, 5.1] | 4.4 [1.7, 5.4] | |
| PLT (104/μL) | 20.4 [3.7, 39.9] | 23.4 [4.5, 38.5] | 21.2 [3.7, 39.9] | |
| AST (IU/L) | 37 [12, 198] | 44 [13, 177] | 40 [12, 198] | |
| ALT (IU/L) | 58 [10, 199] | 65 [9, 198] | 60 [9, 199] |
Data are expressed as median [range] or number.
A, the degree of inflammation’s activity of the hepatitis; ALB, albumin; F, the degree of fibrosis.